Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis

Thorax

Volumn 53, Issue 12, 1998, Pages 1080-1087

  Wells, Athol ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 67;

ALLERGIC PNEUMONITIS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; LUNG LAVAGE; OPEN LUNG BIOPSY; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SIGNAL NOISE RATIO; THORACOSCOPY; THORAX RADIOGRAPHY;

EID: 0031648768     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.12.1080     Document Type: Review

References (67)

1. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987;135:696-704.
2. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis: relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981;124:1-8.
3. Howard P. Clinical usefulness of bronchoalveolar lavage. Eur Respir J 1990;3:377-8.
4. Line BR, Fulmer JD, Reynolds HY, et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis 1978;118:355-65.
5. Panos RJ, Mortensen RL, Niccoli SA, et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990;88:396-404.
6. Mayo JR, Webb WR, Gould R, et al. High-resolution CT of the lungs: an optimal approach. Radiology 1987;163:507-10.
7. Webb WR, Muller NL, Naidich DP, eds. HRCT findings of lung disease. In: High resolution CT of the lung. New York: Raven Press, 1992:4-13.
8. Mayo JR, Jackson SA, Muller NL. High resolution CT of the chest: radiation dose. AJR 1993;160:479-81.
9. Zwirewich CV, Mayo JR, Muller NL. Low dose high resolution CT of lung parenchyma. Radiology 1991;180:413-7.
10. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.
11. Johnston IDA, Prescott RJ, Chalmers JC, et al. British Thoracic Society study of Cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997; 52:38-44.
12. Johnston IDA, Gomm SA, Kalra S, et al. The management of Cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J 1993;6:891-3.
13. Wells AU, Hansell DM, Rubens MB, et al. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993;148: 1076-82.
14. Mathieson JR, Mayo JR, Staples CA, et al. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989;171:111-6.
15. Padley SPG, Hansell DM, Flower CDR, et al. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol 1991;44:227-31.
16. Grenier P, Valeyre D, Cluzel P, et al. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high resolution CT. Radiology 1991;179:123-32.
17. Bergin CJ, Coblentz CL, Chiles C, et al. Chronic lung diseases: specific diagnosis by using CT AJR 1989;152: 1183-8.
18. Tung KT, Wells AU, Rubens MB, et al. The accuracy of the typical CT appearances of fibrosing alveolitis. Thorax 1993;48:334-8.
19. Nishimura K, Izumi T, Kitaichi M, et al. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases. Chest 1993;104:1149-55.
20. Wells AU. High resolution computed tomography in sarcoidosis: a clinical perspective. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 1998 (in press).
21. Silver SF, Muller NL, Miller RR, et al. Hypersensitivity pneumonitis: evaluation with CT. Radiology 1989;173:441-5.
22. Hansell DM, Wells AU, Padley SPG, et al. Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiology 1996;199:123-8.
23. Grenier P, Chevret S, Beigelman C, et al. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT with Bayesian analysis. Radiology 1994;191:383-90.
24. Black WC. How to evaluate the radiology literature (review). AJR 1990;154:17-22.
25. Hansell DM, Wells AU, Tung KT. Accuracy of CT appearances of fibrosing alveolitis (letter). Thorax 1994;49:385-6.
26. Primack SL, Hartman TE, Hansell DM, et al. End-stage lung disease: CT findings in 61 patients. Radiology 1993;189:681-6.
27. Johnston IDA. BTS recommendations on the diagnosis and assessment of diffuse parenchymal lung disease (DPLD). Thorax (Suppl) (in press).
28. Carrington CB, Gaensler EA, Coutu RE, et al. Natural history and treated course of usual and desquamative interstitial pneumonitis, N Engl J Med 1978;298:801-9.
29. Scadding JG, Hinson KF. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967;22:291-304.
30. Winterbauer RH, Hammar SP, Hallamn KO, et al. Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisolone/azathiopnne. Am J Med 1978;65:661-72.
31. Dill J, Ghose T, Landrigen P, et al. Cryptogenic fibrosing alveolitis. Chest 1975;67:411-6.
32. Wells AU, Hansell DM, Harrison NK, et al. Clearance of inhaled Tc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993;6:797-802.
33. Chinet T, Jaubert F, Dusser D, et al. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 1990;45:675-8.
34. Wells AU, Rubens MB, du Bois RM, et al. Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography. Eur Respir J 1997;10:280-5.
35. Muller NL, Miller RR, Webb WR, et al. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986;160:585-8.
36. Wells AU, Hansell DM, Corrin B, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:508-12.
37. Nishimura K, Kitaichi M, Izumi T, et al. Usual interstitial pneumonia: histologic correlation with high resolution CT. Radiology 1992;182:337-42.
38. Remy-Jardin M, Giraud F, Remy J, et al. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189: 693-8.
39. Wells AU, Rubens MB, du Bois RM, et al. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR 1993;161:1159-65.
40. Muller NL, Staples CA, Miller RR, et al. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987;165:731-4.
41. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998;157:1063-72.
42. Coblentz CL, Babcook CJ, Alton D, et al. Observer variation in detecting the radiologic features associated with bronchiolitis. Invest Radiol 1991;26:115-8.
43. Collins CD, Wells AU, Hansell DM, et al. Observer variation in pattern type and extent of disease in tibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 1994;49:236-40.
44. Turner MO. Measuring the clinical impact of thoracic computed tomographic scanning. Thorax 1997;52:404-6.
45. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psych Meas 1973;33:613-9.
46. Muller NL, Kullnig P, Miller RR. The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR 1989;152:1179-82.
47. Staples CA, Gamsu G, Ray CS, et al. High resolution computed tomography and lung function in asbestosis-exposed workers with normal chest radiographs. Am Rev Respir Dis 1989;139:1502-8.
48. Hansell DM, Moskovic E. High resolution computed tomography in extrinsic allergic alveolitis. Clin Radiol 1991;43: 8-12.
49. Stein MG, Mayo J, Muller NL, et al. Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 1987;162:371-5.
50. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990;84:365-9.
51. Wells AU, King AD, Rubens MB, et al. Lone cryptogenic fibrosing alveolitis: a functional morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997;155:1367-75.
52. Doherty MJ, Pearson MG, O'Grady EA, et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997;52:998-1002.
53. Turner-Warwick M, Lebowicz M, Borrows B, et al. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496-9.
54. Peterson MW, Monick M, Hunninghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987;92: 51-6.
55. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994;150:462-8.
56. Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1998;157:1474-82.
57. Haslam PL, Dewar A, Butchers P, et al. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Am Rev Respir Dis 1987;135:35-47.
58. Holman CDJ, Matz LR, Finlay-Jones LR, et al. Interobserver variation in the histopathological reporting of Hodgkin's disease: an analysis of diagnostic subcomponents using kappa statistics. Histopathology 1983;7:399-407.
59. Duncan LM, Berwick M, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993;100: 318-21S.
60. Cherniack RM, Colby TV, Flint A, et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Us 1991;144:892-900.
61. Lynch DA, Newell JD, Logan PM, et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR 1995;165:807-11.
62. Hartman TE, Primack SL, Swensen SJ, et al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187:787-90.
63. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Cm Care Med 1998;157: 199-203.
64. Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995;195:645-8.
65. Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules: the choice of strategy is a close call. Am Rev Respir Dis 1986;134:453-60.
66. Neff TA. The science and humanity of the solitary pulmonary nodule. Am Rev Respir Dis 1985;134:433-4.
67. Costabel U. Management of idiopathic pulmonary fibrosis: academic postulate and clinical practice. Eur Respir J 1993; 6:770-1.